Quality Compounder

401 tickers in this investment thesis
Ranks this page's recent reports by score.
Corpay, Inc.
CPAY·Technology
A ★★★★Buy
Current$367.71
Target$427.20
Return+16.2%
Jul 24, 2026

Corpay pairs explosive, high-margin Corporate Payments growth with relentless share buybacks to guarantee double-digit EPS expansion, though investors must tolerate the leverage risks of its debt-heavy M&A roll-up model.

Score
87
Equity Residential
EQR·Real Estate
B ★★★Hold
Current$68.30
Target$72.00
Return+5.4%
Jul 25, 2026

Equity Residential is an undisputed blue-chip operator primed to monopolize coastal housing via the AvalonBay merger, but currently trades at a full valuation that leaves the stock highly vulnerable to any delays in Federal Reserve rate cuts.

Score
80
Chubb Limited
CB·Financials
S ★★★★★Strong Buy
Current$343.23
Target$395.00
Return+15.1%
Jul 25, 2026

Chubb perfectly pairs elite underwriting discipline (83.8% combined ratio) with massive capital returns, though cyclical softening in commercial property markets demands close monitoring.

Score
96
Marsh & McLennan Companies, Inc.
MRSH·Financials
A ★★★★Buy
Current$176.40
Target$214.70
Return+21.7%
Jul 25, 2026

Marsh McLennan's unparalleled scale and proprietary risk data ensure secular margin expansion, though near-term debt loads and softening commercial insurance pricing demand disciplined management execution.

Score
90
The Charles Schwab Corporation
SCHW·Financials
A ★★★★Buy
Current$101.61
Target$128.00
Return+26.0%
Jul 25, 2026

Charles Schwab is a supreme wealth management compounder poised for massive multiple expansion as the cash sorting crisis fades, though unexpected inflation spikes could temporarily pressure its immense net interest revenue engine.

Score
91
Novartis AG
NVS·Healthcare
B ★★★Hold
Current$156.64
Target$170.00
Return+8.5%
Jul 25, 2026

Novartis offers a fortress-like balance sheet, elite cash generation, and a 3%+ dividend backed by surging oncology assets, but the stock remains deadlocked until upcoming binary pipeline readouts prove the company can outgrow the massive Entresto patent cliff.

Score
76
Equifax Inc.
EFX·Industrials
B ★★★Hold
Current$166.76
Target$220.00
Return+31.9%
Jul 25, 2026

Equifax possesses a cash-gushing, monopolistic data moat via Workforce Solutions trading at a discount, though explosive upside remains capped until the U.S. mortgage market thaws.

Score
81
D.R. Horton, Inc.
DHI·Consumer Discretionary
B ★★★Hold
Current$142.12
Target$156.00
Return+9.8%
Jul 25, 2026

D.R. Horton is an operational juggernaut with an impregnable balance sheet poised to dominate the structural housing shortage, but near-term upside is capped by brutal affordability constraints and margin-diluting rate buydowns.

Score
75
Intuitive Surgical, Inc.
ISRG·Healthcare
B ★★★Hold
Current$340.69
Target$497.87
Return+46.1%
Jul 24, 2026

Intuitive Surgical commands an impenetrable robotic surgery moat with flawless financials, but slowing domestic procedure growth and a demanding valuation warrant a cautious holding stance.

Score
76
Interactive Brokers Group, Inc.
IBKR·Financials
B ★★★Hold
Current$94.42
Target$109.38
Return+15.8%
Jul 24, 2026

Interactive Brokers commands an impenetrable technological moat driving 77% profit margins, but its heavy reliance on elevated interest rates and a steep 38x earnings multiple restrict near-term upside.

Score
81
Danaher Corporation
DHR·Healthcare
A ★★★★Buy
Current$192.50
Target$228.61
Return+18.8%
Jul 24, 2026

Danaher boasts an unmatched quality compounder profile fueled by a proprietary razor-and-blade model, offering an attractive entry point as the market myopically punishes temporary bioprocessing delays that mask robust underlying demand.

Score
85
Netflix, Inc.
NFLX·Communication Services
A ★★★★Buy
Current$68.58
Target$90.00
Return+31.2%
Jul 24, 2026

Expecting the rapid scaling of the high-margin ad-tier and massive share repurchases to drive EPS growth, while remaining vigilant against slowing top-line subscriber momentum and escalating content acquisition costs.

Score
89
General Electric Company
GE·Industrials
B ★★★Hold
Current$349.00
Target$388.72
Return+11.4%
Jul 24, 2026

A highly profitable, wide-moat pure-play aerospace leader with exceptional MRO cash flow, currently trading at a premium valuation that limits near-term upside.

Score
76
Texas Pacific Land Corporation
TPL·Energy
B ★★★Hold
Current$433.10
Target$482.00
Return+11.3%
Jul 23, 2026

Texas Pacific Land offers an unparalleled, high-margin royalty monopoly in the Permian Basin with massive emerging upside from AI data centers, though premium valuation multiples warrant a patient entry.

Score
80
ResMed Inc.
RMD·Healthcare
S ★★★★★Strong Buy
Current$192.91
Target$265.00
Return+37.4%
Jul 23, 2026

ResMed offers an unparalleled opportunity to buy a dominant, high-ROIC medical compounder at a massive discount due to overblown pharmaceutical fears, though a fierce price war from a resurgent Philips remains a critical watchpoint.

Score
96
Sunbelt Rentals Holdings, Inc.
SUNB·Industrials
B ★★★Hold
Current$72.00
Target$84.00
Return+16.7%
Jul 23, 2026

Sunbelt Rentals commands a dominant, cash-printing moat fueled by the industrial reshoring supercycle, but investors must endure near-term margin compression caused by wage inflation and fleet repositioning costs.

Score
83
Tenaris S.A.
TS·Energy
B ★★★Hold
Current$57.16
Target$65.00
Return+13.7%
Jul 23, 2026

Tenaris offers an impenetrable, cash-gushing moat in premium OCTG supported by massive shareholder returns, but remains heavily tethered to the unavoidable cyclicality and geopolitical volatility of global energy markets.

Score
82
Raymond James Financial, Inc.
RJF·Financials
A ★★★★Buy
Current$168.01
Target$195.00
Return+16.1%
Jul 23, 2026

Raymond James combines a highly resilient, fee-based wealth management moat with robust capital returns, though pending cash sweep litigation and interest rate sensitivity warrant careful monitoring.

Score
85
Ryanair Holdings plc
RYAAY·Industrials
B ★★★Hold
Current$58.41
Target$74.00
Return+26.7%
Jul 23, 2026

Ryanair’s unparalleled cost leadership and debt-free balance sheet secure its long-term dominance, though near-term fare compression and multiple premiums suggest a Hold strategy until valuation gaps close.

Score
76